{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-079579","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.578326+00:00","generated_at":"2026-05-31T20:57:47.412212+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Select Medical estimates Concentra Q2 rev $477.9M, op income $83.9M","bullets":["Concentra net operating revenue ~$477.9M for Q2 2024; income from operations ~$83.9M.","Estimates are preliminary, subject to change upon completion of financial close.","Select Medical's full Q2 2024 results expected after market close on August 1, 2024.","Conference call to discuss results and outlook on August 2, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-079579","json":"https://secwatch.observer/filing/0001104659-24-079579.json","markdown":"https://secwatch.observer/filing/0001104659-24-079579.md","text":"https://secwatch.observer/filing/0001104659-24-079579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924079579/0001104659-24-079579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924079579/tm2419380d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:57:47.412212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}